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Hermansky-Pudlak syndrome (HPS) is an autosomal
recessive disorder characterized by the triad of
tyrosinase-positive oculocutaneous albinism, bleed-
ing diathesis due to storage-pool deficiency of plate-
lets, and a lysosomal ceroid storage disease. The
disorder is particularly frequent in Puerto Rico and
in an isolated village in the Swiss Alps. We have used
a linkage disequilibrium mapping approach to localize
the HPS gene in both of these groups to a 0.6
centiMorgan interval in chromosome segment
10q23.1-q23.3. These results indicate that the Puerto
Rican and Swiss forms of HPS are either allelic or
that they result from mutations in very closely linked
genes in this region. This region of distal chromo-
some 10q is syntenic to the region of mouse chromo-
some 19 that includes 'pale ear' (ep) and 'ruby-eye'
(ru), which must be considered as potential murine
homologues to human HPS.
INTRODUCTION
Hermansky-Pudlak syndrome (HPS) is an autosomal recessive
disorder characterized by the triad of tyrosinase-positive oculo-
cutaneous albinism (OCA), a bleeding diathesis, and an appar-
ent lysosomal ceroid storage disease (I). Other symptoms,
including progressive restrictive lung disease, cardiomyopathy,
renal failure, and a granulomatous enteropathy resembling
Crohn's disease, occur frequently. The clinical manifestations
of HPS can be extremely variable, both between and even
within affected sibships. There is no specific or effective
therapy for HPS, and treatment is usually limited to supportive
care. Average survival is 30-50 years or less, and death usually
results from restrictive lung disease (68%), hemorrhage (17%),
or granulomatous colitis (15%) (2). HPS is relatively rare in
most human populations, but is quite prevalent in Puerto Rico,
particularly in the northwestern quarter of the island, where it
occurs with an estimated frequency of approximately 1 per
1800 persons (2). HPS is also very frequent in a long-isolated
village in the Swiss Alps (3,4), although these patients lack
manifestations of ceroid storage and usually have a milder
clinical course with normal life expectancy.
The fundamental defect in HPS is not known, but it is
thought to involve a protein required in common for the
normal function and/or structure of three different organelles:
melanosomes, platelet dense granules, and lysosomes. Albin-
ism in HPS results from a greatly reduced number of fully
melanized melanosomes in skin and hairbulb melanocytes, and
the melanosomes that are present exhibit reduced melanin
content and abnormal internal structure (5), size, and morph-
ology (4,6). Bleeding in HPS results from defective platelet
ADP release and aggregation (7,8) due to a reduced number
of platelet 'dense granules' (9,10), storage pool granules rich
in serotonin, calcium, ADP, ATP, and pyrophosphate (11).
Lysosomal storage in HPS is characterized by the accumulation
of yellow-brown ceroid/lipofuscin-like material in lysosomal
structures of reticuloendothelial cells (1), lung macrophages
(12), gastrointestinal mucosal cells (2), and cells of many other
tissues. In the mouse there are 14 distinct loci in which
mutations result in hypopigmentation associated with platelet
and/or lysosomal defects (13-15), and several of these have
been suggested as possible homologues to human HPS (16-
19).
We have used the approach of linkage disequilibrium map-
ping to localize the human HPS gene to a 0.6 centiMorgan
(cM) interval of chromosome segment 10q23.1-q23.3. First
proposed by Lander and Botstein in 1986 (20), linkage disequi-
librium mapping is particularly well suited to the precise
localization of genes for rare autosomal recessive diseases by
taking advantage of identity by descent (21). In the case of HPS,
the very high frequency of the disorder in the northwestern part
of the island of Puerto Rico probably resulted from occult
inbreeding following descent from a common founder.
Similarly, the Swiss HPS kindred derives from one small
isolated Alpine village, and extensive inbreeding has been
described (3,4). Within each group, the HPS locus should
therefore be in linkage disequilibrium with closely linked
marker alleles or marker allele haplotypes derived from the
founder chromosome. The very large number of meioses since
introduction of the founder chromosome into the population
ensures a very high resolution for genetic mapping purposes.
Because of the considerable differences in disease phenotype
between Puerto Rican and Swiss HPS, we did not expect that
these disorders would necessarily prove identical or even be
allelic. However, the Puerto Rican and Swiss subtypes of HPS
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both map to precisely the same interval in 10q23.1-q23.3,
indicating that either these disorders are allelic or they result
from mutations in very closely linked genes in this chromo-
somal region. This region of human chromosome 10 is syntenic
to that portion of mouse chromosome 19 that includes 'pale
ear' (ep) and 'ruby-eye' (ru) (22), suggesting that one or both
of these mouse mutations may be homologous to human HPS.
RESULTS
Markers were selected to provide generally uniform and
progressively denser coverage of the genome. The first 198
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Figure 1. Genotype analysis of D10S677 in patients with HPS. Lane M,
molecular size standard. Lanes 1-8, Puerto Rican HPS patients 1-8. Lanes
9-14, Swiss HPS patients 1-6.
markers tested, variably distributed over all 22 autosomes,
showed no evidence of linkage disequilibrium with HPS.
However, marker D10S677 exhibited striking linkage disequi-
librium both in the Puerto Rican and in the Swiss HPS groups.
As shown in Figure 1, all eight Puerto Rican HPS probands
shared the 213 bp allele 1 of D10S677, and three were
homozygous for this allele. Similarly, all six affected members
of the Swiss HPS kindred shared the 201 bp allele 2 of
D10S677, and five were homozygous for this allele. The
probability of obtaining 11 of 16 independent chromosomes
in the Puerto Rican group sharing one allele at any of 199
markers on the basis of chance is approximately 0.285 (modeled
assuming nine alleles for each marker with trie allele frequen-
cies as reported for D10S677; ref. 23). Furthermore, we also
determined the D10S677 genotype for all 32 members of the
Swiss HPS kindred, and by genetic linkage analysis calculated
a maximum lod score of 1.99 at 9 = 0.00 (Table 1). Although
not definitive, together these results suggested both that a HPS
gene might be located near D10S677 and also that the Puerto
Rican and Swiss HPS patients might have mutations at the
same locus on lOq, or at least at closely-linked loci.
To confirm the possible linkage of D10S677 to one or more
human HPS loci, and to further localize the HPS gene, we
genotyped the eight Puerto Rican HPS probands and the six
affected Swiss HPS patients for 11 additional polymorphic
markers in the close vicinity of D10S677 (23) (Fig. 2). For
most of these markers all eight Puerto Rican patients shared
at least one common allele and multiple individuals were
homozygous for this allele. Similar data were observed for the
six Swiss HPS patients. For some of the markers, maximum
lod scores in the Swiss kindred were well in excess of 3
(Table 1).
Table 1. Two point lod scores for HPS and chromosome lOq markers in the Swiss kindred
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To reduce computational time, the highly inbred Swiss HPS kindred was split into four sub-families, most likely greatly reducing maximum lod scores and
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Figure 2. Chromosome lOq marker haplotypes in Puerto Rican and Swiss HPS patients and their immediate families. (A) Puerto Rican. (B) Swiss. Haplotypes
or portions of haplotypes inferred as being ancestrally related to HPS are boxed. Alleles are as described in ref. 21, except for novel alleles, which are indicated
by asterisks. Double-headed arrows denote the most likely interval for the HPS locus. Detailed pedigrees of the extremely large and complex Swiss HPS kindred
have been reported elsewhere (3,4); the individuals shown in generation I are all related to virtually all of each other. Numerous additional individuals in the
Swiss HPS kindred were studied for the lod score analyses in Table 1.
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Figure 3. Genotype analysis of D10SI10/D10S184 in patients with HPS. (A)
D10S110. (B) D10S184. Lanes are as described in Figure 1.
Two markers, D10S110 and D10S184, located near the
middle of this region (23), were homozygous for one allele in
all eight Puerto Rican HPS probands and for a different allele
in all six Swiss HPS patients (Figs 2 and 3). The probability
of homozygosity for any single allele of D10S110 in eight
unrelated Puerto Rican individuals on the basis of chance is
2.8 X10"4, and the maximum lod score for D1 OS 110 in the Swiss
kindred was 0.82 at 6 = 0. The probability of homozygosity for
any single allele of Dl OS 184 in eight unrelated Puerto Rican
individuals by chance is 9.4X 10"5, and the maximum lod score
in the Swiss kindred was 0.88 at 0 = 0. However, analysis of
the primer sequences for D10S110 and D10S184, which map
0 cM from each other (23), suggest that they most likely
define the same polymorphic microsatellite; therefore, these
markers should probably not be considered independent.
As shown in Figure 2, apparent ancestral marker haplotypes
associated with HPS were easily derived in both the Puerto
Rican and Swiss HPS patients. The frequency of apparent
recombination events with HPS tended to increase in both
directions from the completely homozygous marker D10S110/
D10S184. In both the Puerto Rican and Swiss HPS patients
recombinants were observed between D10S110/D10S184 and
D10S577 or D10S198, which flank D10S110/D10S184 0.3
cM to the centromeric and telomeric sides, respectively. These
data thus strongly indicate that the Puerto Rican and Swiss
forms of HPS are either allelic or involve very closely linked
loci situated within the 0.6 cM interval defined by D10S577
and D10S198, probably close to D10S110/D10S184.
DISCUSSION
We have mapped the HPS locus to a 0.6 cM interval flanked
by D10S577 and D1 OS 198 and centered on D1 OS 110/D1 OS 184.
D10S110 has been mapped by FISH to chromosome segment
10q23.1-q23.3 (24), establishing this chromosome segment as
the cytogenetic location of the human HPS locus. Despite
evident phenotypic differences between the Puerto Rican and
the Swiss forms of HPS, we found no evidence for genetic
heterogeneity; both mapped to this same location. Nevertheless,
we cannot exclude the possibility that these two forms of the
disorder result from defects in closely linked genes, perhaps
members of a gene family. This is not a purely formal
distinction, as two of the 14 different mouse loci associated
with HPS-like recessive mutant phenotypes are located very
close together in a region of mouse chromosome 19 that is
syntenic to this region of distal human chromosome lOq (22).
These two loci, 'pale ear' (ep) and 'ruby-eye' {ru), are both
associated with reduced coat and eye pigment, misrouting of
optic tract neurons, abnormal melanosomes, abnormalities of
lysosomal enzymes, and deficiency of platelet dense granules
and prolonged bleeding time; phenotypes very similar to
human HPS. Although ep and ru are each referenced by only
one mutant allele (13,14), these two loci appear to be non-
allelic (25), and map about 2 cM apart (map positions 42 and
44, respectively), between Tdt and Cypl7 (26). Neither ep nor
ru has been cloned, and thus neither has been mapped precisely
relative to the human genome. However, human TDT maps to
10q23-q24, and human CYP17 to 10q24.3 (27), coincident
with the most likely location of the human HPS gene. Therefore,
both ep and ru must be considered as potential murine
homologues to human HPS.
No known human genes or ESTs have been mapped into
this 0.6 cM interval on lOq. It thus seems probable that a
positional cloning approach will be required for the eventual
isolation of the HPS gene itself. Nevertheless, our precise
localization of the HPS gene will permit an immediate improve-
ment in the accuracy of genetic counseling of families in the
Swiss and Puerto Rican groups at high risk for HPS. Ultimately,
identification of the HPS gene should facilitate definition of
its function, greatly enhancing future efforts to develop specific
effective therapeutic modalities for HPS, both pharmacologic
and DNA-based.
MATERIALS AND METHODS
Patients
Blood samples for DNA analysis were collected from 32 members of the
Swiss HPS kindred (3,4), including six affected individuals in four nuclear
families. All individuals were examined by one of the authors. Blood samples
for DNA analysis were collected from members of 35 unrelated Puerto Rican
HPS nuclear families, including 40 affected individuals. Many had previously
been studied from a clinical standpoint (2) and tested positive for HPS by
lack of platelet dense granules. In none of these families were the parents
knowingly consanguineous, although all families came from northwestern
Puerto Rico, principally from the towns of Arecibo, San Sebastian, and Moca.
All individuals were examined by at least one of the authors. Eight unrelated
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probands with unequivocal clinical findings of HPS were selected for map-
ping studies.
Genotype analysis
High-molecular weight DNA was prepared and genotyped using a panel of
363 polymorphic microsatellite PCR markers (Human Screening Set Version
5; Research Genetics, Inc.) by standard procedures (28). For each marker
pooled DNAs of three unrelated normal Caucasians were genotyped in parallel
as a control. One primer of each pair was end-radiolabeled with 32[P] and
the PCR products were analyzed by denaturing gel electrophoresis and
autoradiography. In most cases two different markers that yielded quite
disparately-sized PCR products were amplified and analyzed in multiplex.
Scoring was by visual inspection, and allele sizes were assigned by comparison
to 32[P]-radiolabeled DNA molecular size standards also on the gel and by
parallel analyses of CEPH pedigree members 1331-01 and 1331-02 as
standards. Markers in the region of D10S677 were identified from public
databases (23), and corresponding PCR primer pairs were synthesized or
purchased from Research Genetics, Inc. and used to genotype the Puerto
Rican HPS patients, some of their parents, and all available members of the
Swiss HPS kindred as above.
Linkage analysis
Pairwise lod scores were calculated for the Swiss HPS kindred using the
MLINK and ILINK programs of the LINKAGE package (Ver. 5.1) (29). The
disease was considered to be autosomal recessive with a frequency of 10~5.
Allele frequencies for the markers were as reported in public databases (23),
except for D10S110 and D1 OS 184, for which we determined allele frequencies
by genotyping eight unrelated normal Puerto Rican individuals as described
above.
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